why choose us

First received: June 08, 2023

Clinical Trial: Decitabine for Poor Graft Function Post Allo-HSCT

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Poor Graft Function

Study Type: INTERVENTIONAL


Official Title: Low Dose Decitabine for Poor Graft Function Post Allogenic Hematopoietic Stem Cell Transplantation

Brief Summary: This randomized trial aims at validating the efficacy and safety of low-dose decitabine for PGF post allo-HSCT.

Read more